Ami Asset Management Corp Verona Pharma PLC Transaction History

Ami Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	SELL	$53.9 - $98.68 $1.05 Million - $1.93 Million	-19,561 Reduced 46.37%	22,624 $2.14 Million
Q1 2025 Apr 23, 2025	SELL	$44.81 - $69.63 $72,592 - $112,800	-1,620 Reduced 3.7%	42,185 $2.68 Million
Q4 2024 Jan 16, 2025	SELL	$28.71 - $47.02 $647,152 - $1.06 Million	-22,541 Reduced 33.97%	43,805 $2.03 Million
Q3 2024 Oct 25, 2024	SELL	$15.46 - $30.16 $56,490 - $110,204	-3,654 Reduced 5.22%	66,346 $1.91 Million
Q2 2024 Jul 24, 2024	BUY	$11.48 - $17.02 $803,600 - $1.19 Million	70,000 New	70,000 $1.01 Million

264

78.7M

686K

442K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $6.52B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Ami Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Ami Asset Management Corp with notifications on news.